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Abstract
In Parkinson’s disease, subthalamic nucleus (STN) neurons burst fire with increased periodicity 
and synchrony. This may entail abnormal release of glutamate, the major source of which in STN 
is cortical afferents. Indeed, the cortico-subthalamic pathway is implicated in the emergence of 
excessive oscillations, which are reduced, as are symptoms, by dopamine-replacement therapy or 
deep brain stimulation (DBS) targeted to STN. Here we hypothesize that glutamatergic synapses 
in the STN may be differentially modulated by low-frequency stimulation (LFS) and high-
frequency stimulation (HFS), the latter mimicking deep brain stimulation. Recordings of evoked 
and spontaneous excitatory post synaptic currents (EPSCs) were made from STN neurons in brain 
slices obtained from dopamine-intact and chronically dopamine-depleted adult rats. HFS had no 
significant effect on evoked (e) EPSC amplitude in dopamine-intact slices (104.4±8.0%) but 
depressed eEPSCs in dopamine-depleted slices (67.8±6.2%). Conversely, LFS potentiated eEPSCs 
in dopamine-intact slices (126.4±8.1%) but not in dopamine-depleted slices (106.7±10.0%). 
Analyses of paired-pulse ratio, coefficient of variation, and spontaneous EPSCs suggest that the 
depression and potentiation have a presynaptic locus of expression. These results indicate that the 
synaptic efficacy in dopamine-intact tissue is enhanced by LFS. Furthermore, the synaptic efficacy 
in dopamine-depleted tissue is depressed by HFS. Therefore the therapeutic effects of DBS in 
Parkinson’s disease appear mediated, in part, by glutamatergic cortico-subthalamic synaptic 
depression and implicate dopamine-dependent increases in the weight of glutamate synapses, 
which would facilitate the transfer of pathological oscillations from the cortex.
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The cardinal motor symptoms of Parkinson’s disease (PD) are coincident with the loss of 
independent neuronal activity in the cortex and nuclei of the basal ganglia (BG). Thus, in the 
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presence of normal dopaminergic “drive,” the activity of BG neurons is largely 
desynchronized. However, in idiopathic PD and its experimental models, neurons of the 
external globus pallidus (GP) and subthalamic nucleus (STN), amongst others in the BG, 
loose their independence and show increases in burst firing and synchronization (Filion and 
Tremblay, 1991; Bergman et al., 1994; Nini et al., 1995). During the slow-wave activity 
prominent in sleep and general anesthesia, this pathological activity favors low-frequency 
oscillations (<2 Hz) that are synchronized to ongoing slow cortical rhythms (Magill et al., 
2001; Mallet et al., 2008a). During wakefulness or analogous brain states, this pathological 
activity favors oscillations at beta (15–30 Hz) frequencies (Brown et al., 2001; Sharott et al., 
2005; Kühn et al., 2006; Mallet et al., 2008a,b), which may underlie rigidity and 
bradykinesia (Levy et al., 2000; Eusebio et al., 2011). Pathological beta oscillations and 
motor symptoms may be reversed by dopamine replacement therapy (Brown et al., 2001; 
Kühn et al., 2006), or by lesions or high-frequency (>100 Hz) stimulation (“deep brain 
stimulation” or DBS) directed to STN (Bergman et al., 1994; Eusebio et al., 2011).
Using an organotypic culture preparation, Plenz and Kitai (1999) proposed that the GP and 
STN constitute a central pacemaker responsible for oscillatory activity, at least at low 
frequencies (<3 Hz). However, this proposal has not been supported in vitro (Loucif et al., 
2005) or in vivo (Magill et al., 2000, 2001). Instead, these studies point to a critical role of 
the cortex and STN in sculpting BG neuronal activity through the glutamatergic 
“hyperdirect” cortico-subthalamic pathway (Fujimoto and Kita, 1993; Maurice et al., 1998; 
Nambu et al., 2000; Magill et al., 2001, 2004; Sharott et al., 2005; Mallet et al., 2008a,b; 
Litvak et al., 2011). Moreover, several reports indicate that, although the STN is the target 
of choice for surgical intervention therapies in PD, stimulation of the motor cortex also 
provides relief from symptoms (Pagni et al., 2003; Drouot et al., 2004; Lefaucheur et al., 
2004).
As stimulation parameters for DBS are similar to the “tetanizing” protocols used for the 
study of synaptic plasticity in many brain areas, we hypothesized that the beneficial effects 
of DBS arise, at least in part, as a consequence of the modulation of the efficacy of cortico-
subthalamic synapses and a reversal of the pathological effects of dopamine depletion. 
Indeed, dopamine depletion leads to the generation of large compound excitatory 
postsynaptic currents (EPSCs) in the STN (Ammari et al., 2011), presumably as a 
consequence of a loss of inhibitory control of excitatory inputs by dopamine acting at 
presynaptic dopamine D2 receptors (Shen and Johnson, 2000).
In this study, we have used high-frequency stimulation (HFS) of glutamatergic STN 
afferents to mimic DBS, and low-frequency stimulation (LFS) to mimic pathological 
bursting activity, in both dopamine-intact and chronically dopamine-depleted brain slices. 
We show that LFS increases the weight of glutamatergic synaptic inputs in dopamine intact 
tissue, whereas HFS elicits synaptic depression in dopamine-depleted tissue.
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EXPERIMENTAL PROCEDURES
All the animals in this study were used in accordance with the Animals (Scientific 
Procedures) Act, 1986 (UK) and the European Communities Council Directive (80/609/
EEC).
Brain slice preparation
Parasagittal brain slices (300 μm thick) were prepared from young adult (45–52 days of age, 
180–220 g) male Wistar rats. These animals were inbred from a colony originally obtained 
from Charles River (Kent, UK). Animals were first anaesthetized using isoflurane (2% in 
O2) and decapitated. Slices were cut on a DTK-1000 Microslicer (Dosaka, Japan) in ice-cold 
sucrose-based solution containing (in mM) sucrose, 206; KCl, 2; MgSO4, 1.6; NaHCO3, 
25.9; NaH2PO4, 1.25; glucose, 10; and CaCl2, 2.16. Slices were then transferred and 
incubated at room temperature for 1 h in artificial cerebrospinal fluid (aCSF) containing (in 
mM) NaCl, 126; KCl, 2.95; MgSO4, 1.6; NaHCO3, 25.9; NaH2PO4, 1.25; glucose, 10; 
CaCl2, 2; and ascorbic acid, 0.2. Both solutions were continuously aerated with 95% O2 and 
5%CO2, maintaining pH at 7.3 and 310 mOsm. Slices were then transferred to a recording 
chamber and perfused with aCSF at 34 °C at a rate of 2 ml min−1. The whole STN and 
individual STN neurons were visualized by differential interference contrast (DIC) infrared 
microscopy using an Olympus BX51W1 microscope with a CCD camera (KP-M1; Hitachi, 
Tokyo, Japan).
Electrophysiology
Whole-cell voltage-clamp recordings were made using borosilicate glass pipettes (3–4 MÙ 
resistance). Electrodes were filled with an internal solution containing (in mM) HEPES, 40; 
QX-314, 5; EGTA, 0.6; NaCl, 4; D-gluconate, 100; TEA-Cl, 5; ATP-Na, 4; and GTP-Na, 0.3 
(titrated with CsOH to pH 7.25) at 295 mOsm. The concentration of EGTA was set at 0.6 
mM so as not to compromise potential plasticity involving calcium-dependent postsynaptic 
mechanisms. Synaptic currents were recorded at a holding potential of −60 mV using an 
Axopatch 200B amplifier (Molecular Devices Corp., Sunnyvale, CA, USA). Series 
resistance (range: 3–20 MÙ) was monitored throughout each experiment. Results from cells 
where series resistance changed over 20% or was >20 MÙ were discarded. The GABAA 
receptor channel blocker picrotoxin (50 μM) was present in the perfusate throughout all 
recordings. In experiments from dopamine-intact controls, the nonspecific dopamine 
receptor agonist apomorphine was bath applied at a concentration of 20 μM.
Stimulation protocols
Focal electrical stimulation was carried out using glass electrodes filled with normal aCSF. 
To evoke excitatory postsynaptic currents (eEPSCs) mediated by the cortico-subthalamic 
pathway, each stimulating electrode was placed in the rostral internal capsule, at a distance 
of at least 200 μm from the recorded STN cell. To assess the lasting effects of LFS and HFS, 
pairs of stimuli were delivered every 10 s, with an interstimulus interval of 50 ms. 
Stimulation was carried out via a DS-3 constant-current isolated stimulator (Digitimer Ltd., 
Welwyn Garden City, UK), and its parameters (amplitude and width) were adjusted on a 
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cell-by-cell basis to produce 75% of maximum eEPSC amplitude. Stable baseline recordings 
were made for at least 10 min before HFS or LFS.
HFS consisting of 100 pulses at 100 Hz was chosen to mimic DBS. LFS was generated by 
delivering 40 Hz stimulation (10 pulses) every 1 s for 5 min. This latter paradigm mimics 
the pathological activity of STN neurons that emerges during the slow-wave activity brain 
state in anaesthetized 6-hydroxydopamine-lesioned rats (Magill et al., 2001). HFS and LFS 
paradigms were programed in Clampex 10.2.
Data acquisition and analysis
Data were low-pass filtered at 2 kHz by an 8-pole Bessel filter (Axopatch 200B amplifier), 
and digitized at 10 kHz using a Digidata 1440A. Analysis was performed off-line using 
Clampfit 10.2 (Molecular Devices, Sunnyvale, CA, USA). Paired EPSCs (P1 and P2) were 
evoked by single-shock electrical stimulation of equal strength and duration, at an 
interstimulus interval of 50 ms and any changes in the paired pulse ratio (PPR) taken as 
indication of presynaptic locus of expression (Thomson, 2000). PPRs were calculated by 
dividing the mean amplitude of second response (P2) by the mean amplitude of first 
response (P1), thus avoiding facilitatory bias (Kim and Alger, 2001). Ten minutes of 
baseline (pre-LFS or HFS) data were compared with 10 min epochs of data throughout the 
duration of recording after LFS or HFS. Only data showing stable baseline amplitudes, 
defined as those having a coefficient of variation <0.15, were analyzed using one-way 
ANOVAs.
The interevent interval (IEI) of spontaneous EPSCs (sEPSCs) was analyzed off-line using 
Mini-Analysis Programe (Synaptosoft, USA). The significance of shifts in cumulative 
probability distributions was assessed using the Kolmogorov–Smirnov test (KS test). Ten 
minutes of data were compared with the number of events always being >100. To compare 
pooled data before and after stimulation, we determined median IEI values for each cell and 
calculated the mean of these median values for each cell population. All data are expressed 
as mean±SEM and significance for all statistical tests was set at P<0.05.
To confirm the locus of plasticity, coefficient of variation (CV) analysis was also undertaken 
(Bekkers and Stevens, 1990). This is a form of nonstationary fluctuation analysis that allows 
synaptic characteristics to be determined when it is impractical to create conditions for 
altered release probability. Quantal theory describes changes in release probability (P) and 
number of release sites (N) at a presynaptic locus, whereas changes in response amplitude 
(Q) are postsynaptic. The mean amplitude of an EPSC represents the product of N, P, and Q, 
and the coefficient of variation (CV−2) is proportional to NP/1–P. Therefore, any 
presynaptic changes will affect CV−2 and be independent of Q. Thus, using a plot of mean 
amplitude (Q) against CV−2, a response that moves along the x-axis indicates a postsynaptic 
locus of expression, whereas a response that moves along the diagonal indicates a 
presynaptic locus of expression.
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6-hydroxydopamine lesions and behavioral testing
Unilateral 6-hydroxydopamine (6-OHDA) lesions were carried out on 150–180 g rats, as 
described previously (Magill et al., 2001). Briefly, anesthesia was induced and maintained 
with isoflurane (1.5–2.5% in O2). Twenty five minutes before the injection of 6-OHDA, all 
animals received a bolus of desipramine (25 mg kg−1 i.p.; Sigma) to minimize the uptake of 
6-OHDA by noradrenergic neurons (Schwarting and Huston, 1997). Immediately before use, 
the neurotoxin 6-OHDA (hydrochloride salt; Sigma) was dissolved in ice-cold 0.9% w/v 
NaCl solution containing 0.02% w/v ascorbate to a final concentration of 4 mg/ml. Three 
micro liters of 6-OHDA solution was then injected at a rate of 0.6 μl/min into the region 
adjacent to the medial substantia nigra (4.5 mm posterior of bregma, 1.2 mm lateral to the 
midline, and 7.9 mm ventral to the dura).
The extent of the dopamine cell lesion was assessed by the forelimb stepping test (Olsson et 
al., 1995). Behavioral tests were performed 12 or 15 days after the injection of toxin. Each 
animal was tested twice per day for three consecutive days. Each of the animals used for 
electrophysiology showed significant deficits in forelimb stepping on the side contralateral 
to the lesion (ipsilateral 13.5±1.6 steps vs. contralateral 0.47±0.13 steps, n=10, P<0.0001). 
These observed behavioral changes indicate loss of the majority of dopamine neurons. 
Indeed, behavioral deficits of this magnitude not only correlate with significant reductions in 
tyrosine hydroxylase-expressing (dopaminergic) neurons but also with increased oscillatory 
activity in the BG (Tseng et al., 2005). All electrophysiological recordings were performed 
2–5 weeks after injection of toxin, which corresponds to a time when the pathophysiological 
state has stabilized at a maximum level (Pan and Walters, 1988; Vila et al., 2000).
RESULTS
In the presence of picrotoxin (50 μM), stimulation within the internal capsule elicited a 
short-latency (monosynaptic) inward current that reversed around 0 mV and was blocked by 
glutamate receptor antagonists CNQX (10 μM) and D-AP5 (50 μM). At a stimulation 
frequency of 0.1 Hz, no potentiation or rundown of these synaptic responses and no changes 
in intrinsic properties such as resting membrane potential (monitored by changes in holding 
current) or input resistance were observed.
A previous study (Shen et al., 2003) indicated that the response of STN neurons to HFS was 
highly variable, such that potentiation, depression, or no changes were observed. We 
hypothesized that this could be owing to differing concentrations of dopamine release in 
STN within each brain slice (Cragg et al., 2004), leading, in turn, to an inconsistent level of 
dopamine receptor activation. Therefore, in control experiments (slices from dopamine-
intact rats), we added the nonspecific dopamine receptor agonist apomorphine (20 μM) to 
the perfusate to mimic the “tonic” dopamine receptor activation that likely occurs locally in 
the STN in the intact brain (see Cragg et al., 2004) and provide maximum contrast between 
control slices and those slices obtained from 6-OHDA-lesioned animals. Addition of 
apomorphine (20 μM) elicited an inward current indicative of membrane depolarization, and 
an increase in input conductance, as previously observed after application of both receptor 
agonists and exogenous dopamine (Cragg et al., 2004; Loucif et al., 2008). These 
postsynaptic effects were accompanied by a decrease in eEPSC amplitude consistent with 
YAMAWAKI et al. Page 5
Neuroscience. Author manuscript; available in PMC 2014 November 27.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
previous observations. For each stimulation protocol, we assessed evoked (e)EPSC (P1) 
amplitudes and paired pulse ratios (P2/P1), and we performed a CV analysis of spontaneous 
(s)EPSCs.
In the first series of experiments, we examined the effect of HFS, consisting of 100 pulses at 
100 Hz used to mimic DBS, on glutamatergic synaptic responses of STN neurons in slices 
from control (dopamine-intact) animals. No significant changes in P1 EPSP amplitude 
(104.4±8.0%, n=8 neurons, P>0.05, Fig. 1A, B) or PPR (P2/P1, 0.87±0.09 and 0.87±0.07 at 
baseline and post-HFS, respectively, n=8, P>0.05, Fig. 1B, C) were observed after HFS. We 
next addressed the synaptic variability using CV analysis, which again yielded no evidence 
for changes in Q, N, or P (Fig. 1D). Furthermore, no change in the IEI of sEPSCs was 
observed 20 min following HFS (P=0.8, KS test, Fig. 1E, F). Therefore, in dopamine-intact 
slices and in the presence of dopamine receptor activation, HFS had no effect on the efficacy 
of the glutamatergic synapses.
We next examined the effect of HFS on glutamatergic synaptic responses of STN neurons in 
slices obtained from dopamine-depleted animals. In contrast to the scenario in slices from 
dopamine-intact animals, HFS of the cortico-subthalamic pathway in dopamine-depleted 
animals induced a short-term depression of P1 amplitude, lasting for approximately 2 min, 
followed by a longer lasting depression (67.8±6.2%, n=6, P<0.01 Fig. 2A, B), which was 
recorded for at least 30 min. The depression of P1 following HFS was accompanied by a 
significant change in PPR (0.89±0.07 and 0.97±0.03 at baseline and post-HFS, respectively, 
n=6, P<0.05, Fig. 2B, C). A significant presynaptic component was also evident in the CV 
analysis, which showed a pronounced movement along the diagonal toward origin that is 
indicative of a reduction in release probability and/or number of release sites (Fig. 2D). 
These data correlated with the effect of HFS on sEPSCs because the IEI was significantly 
increased 20 min after stimulation, as compared with baseline (P<0.005, KS test, Fig. 2E, 
F). Thus HFS, which had no effect on excitatory inputs to STN neurons in dopamine-intact 
slices, produces a marked synaptic depression of glutamate responses after chronic 
dopamine depletion. This plasticity showed a clear presynaptic component in its locus of 
expression.
In a third series of experiments, we examined the effect of LFS (40 Hz stimulation, 10 
pulses every 1 s for 5 min) to mimic the cortically driven bursting activity seen in the STN 
in vivo (Magill et al., 2001). In dopamine-intact slices (with 20 μM apomorphine), LFS 
promoted a potentiation of P1 amplitude for the following 30 min (126.4±8.1%, n=7, 
P<0.01, Fig. 3A, B). Although no significant changes in PPR were observed (0.79±0.1 and 
0.75±0.06 at baseline and post-LFS, respectively, n=7, P>0.05, Fig. 3B, C), analysis of CV 
showed movement along the diagonal away from the origin indicative of increases in either 
probability of release and/or number of release sites (Fig. 3D), that is, in the opposite 
direction from changes observed after HFS in dopamine-depleted slices. These data 
correlated with analysis of sEPSC and a decrease in IEI (increase in frequency) 20 min after 
LFS (P<0.05, KS test, Fig. 3E, F). Therefore, in contrast to HFS, LFS in dopamine-intact 
slices produces a marked potentiation in synaptic weight of glutamatergic synapses, which 
also showed a presynaptic locus of expression.
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Finally, we examined the effect of LFS on glutamatergic synaptic responses of STN neurons 
in slices obtained from dopamine-depleted animals. In this case, LFS induced a short-lived 
depression that immediately followed the stimulation protocol, but no significant longer-
lasting changes in P1 amplitude were observed (106.7±10.0%, n=6, P>0.05, Fig. 4A, B). 
There was also no significant change in PPR (0.97±0.09 and 1.01±0.08 at baseline and post-
LFS, respectively, P>0.05 Fig. 4B, C). There was a small change in CV along the diagonal 
(Fig. 4D), but this was not associated with amplitude changes in P1, PPR, and IEI of 
sEPSCs (P>0.05, KS test, Fig. 4E, F). Therefore, the significant potentiation of 
glutamatergic EPSCs induced by LFS in dopamine-intact slices is not replicated in slices 
obtained from dopamine-depleted animals.
DISCUSSION
We have shown that LFS, which mimics pathological cortically driven bursting activity in 
STN, promoted potentiation of glutamatergic (cortico-subthalamic) synaptic inputs but only 
in dopamine-intact tissue. Similarly, HFS promotes synaptic depression but only in 
dopamine-depleted tissue, indicating that the beneficial effects of DBS may be mediated, in 
part, by depression of cortico-subthalamic synapses (Fig. 5). Taken together, these results 
suggest that the synaptic weight of the cortico-subthalamic pathway is dynamically 
modulated by ambient concentrations of dopamine, such that it is reduced in dopamine-
intact animals and increased in the dopamine-depleted Parkinsonian state. We propose that 
the increase in the relative weight of cortico-subthalamic synapses in the Parkinsonian 
animal is one way by which the STN becomes sensitized to oscillatory cortical inputs, 
resulting in increased pathological bursting activity in STN that is coherent with cortical 
activity (Magill et al., 2001; Sharott et al., 2005; Mallet et al., 2008a,b).
Experimental considerations
The STN contains a relatively homogenous population of glutamatergic projection neurons 
(Nakanishi et al., 1987; Beurrier et al., 1999; Bevan et al., 2002; Loucif et al., 2008). It 
receives extensive, topographically organized inputs from ipsilateral frontal neocortex, 
including motor and premotor areas (Smith et al., 1998; Nambu et al., 2000). Afferent inputs 
arising in these cortical areas have a powerful synchronizing effect on ensembles of STN 
neurons (Magill et al., 2004), and provide a good substrate for the entrainment of STN firing 
to ongoing cortical oscillations (Magill et al., 2000, 2001; Mallet et al., 2008a,b).
Unfortunately, the synaptic weight of cortico-subthalamic inputs cannot be directly tested by 
simply measuring basal synaptic transmission in control and dopamine-depleted slices. This 
would require that the cortex is the only source of glutamatergic input to STN. This is not 
the case as glutamatergic neurons of the intralaminar thalamus and mesopontine tegmentum 
also innervate the STN (Bevan et al., 1995; Bevan and Bolam, 1995). One would also have 
to assume that these inputs are unaffected by dopamine-depletion. However, given that the 
cortex provides the majority of the glutamatergic inputs to STN that course through the 
internal capsule (Kitai and Deniau, 1981; Nambu et al., 2000), we assume that our electrical 
stimuli evoked glutamate release from cortically derived axon terminals. We have only 
assessed spontaneous EPSCs because assessment of miniature EPSCs in the presence of 
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tetrodotoxin, the usual strategy for determination of presynaptic versus postsynaptic effects, 
is not compatible with HFS and LFS. We acknowledge that data relating to changes in 
sEPSC frequency alone cannot be used to definitely determine locus of action. However, 
changes in sEPSC frequency, without changes in holding potential or input resistance, 
combined with paired pulse and CV data provides ample evidence for a presynaptic 
component of plasticity.
STN neurons recorded in vivo from 6-OHDA-lesioned animals display a 2–3-fold increase 
in the magnitude of their bursting activity in time with the cortex as compared with STN 
neurons in dopamine-intact controls (Magill et al., 2001). This abnormal bursting during 
slow-wave sleep may also lead to the reinforcement of synaptic weights, particularly along 
the cortico-subthalamic pathway. The LFS protocol utilized in this study mimics this 
pathological, slow busting activity, whereas HFS at 100 Hz mimics DBS. We acknowledge 
that longer duration HFS may produce more robust plastic changes, and that this may be 
viewed more analogous to DBS. However, as short duration stimulations were sufficient to 
induce plasticity, and longer duration stimulations compromise cell viability, the stimulation 
protocols employed here allow extended good-quality recordings and tests of plasticity, 
while relating to the protocols used clinically. Indeed, both LFS and HFS employed here are 
similar to those used in many other synaptic plasticity studies both in vitro and in vivo.
Mechanism of DBS
As the beneficial effects of DBS targeted to the STN were similar to STN lesions, the 
mechanism originally proposed for DBS efficacy involved functional inhibition of the STN, 
including through depolarization block and/or functional deafferentation (Benazzouz et al., 
1993; Benazzouz and Hallett, 2000). More recently, multiple effects of DBS have been 
described including local changes in neuronal excitability, enhanced GABA and glutamate 
release, axonal activation and axonal block (see Deniau et al., 2010 for review) as well as 
stimulus induced modulation of pathological activity (Hammond et al., 2008).
The fact that lesions of the STN have beneficial effects in animal models of PD, and that the 
behavioral effects of HFS were similar to those of lesions, led to the STN being the 
preferred site of stimulation (Benazzouz et al., 1993; Krack et al., 2003). However, this does 
not necessarily establish a leading role for the STN in generating all pathological activity in 
Parkinsonism. Indeed there is an argument that the STN is an efficacious site of stimulation 
because of its small volume and nodal point within BG circuitry. Recent evidence has 
implicated the cortex not only in the generation of pathological activity but also as a 
potential target both for pharmacological and surgical interventions in modulating such 
activity. Thus, HFS of cortex appears to normalize firing rates in the Parkinsonian STN and 
reduce akinesia and bradykinesia (Drouot et al., 2004; Pagni et al., 2005). Furthermore, 
repetitive transcranial magnetic stimulation improves motor performance in PD (Siebner et 
al., 2000; Khedr et al., 2003; Lefaucheur et al., 2004; Fregni et al., 2006). These findings are 
supplemented by reports that DBS of the STN promotes antidromic stimulation of cortical 
networks implicated in the generation of pathological oscillations in PD (Li et al., 2007; 
Lehmkuhle et al., 2009), with the magnitude of antidromic activation correlating with the 
suppression of pathological beta activity. In addition, any antidromic (and thence, 
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orthodromic) activation of neuronal networks within the cortex would directly modulate and 
perhaps negate the oscillatory activity being transferred from cortex to STN. However, one 
of the most compelling pieces of evidence implicating the cortico-subthalamic pathway in 
the beneficial effects of HFS is a recent optogenetic study that allowed the precise role of 
different nuclei and axonal projections to be determined in behaving Parkinsonian rodents. 
Thus, the therapeutic effects of DBS were only accounted for by direct stimulation of 
afferents projecting to the STN, and specifically, those arising from layer V cortical neurons, 
again implicating the cortico-subthalamic pathway (Gradinaru et al., 2009).
The frequency- and dopamine-dependency of changes in the plasticity profile of the cortico-
subthalamic pathway presented here add further to the weight of evidence that this pathway 
plays a central role in PD pathology. Low-frequency stimulation potentiated glutamatergic 
(cortico-subthalamic) synaptic inputs in dopamine-intact tissue only, and HFS promoted 
synaptic depression in dopamine-depleted tissue only, suggesting that the synaptic weight of 
the cortico-subthalamic pathway is dynamically modulated by dopamine. Furthermore, these 
results further promote the view that the beneficial effects of DBS are at least in part owing 
to stimulation of the cortico-subthalamic pathway.
Synaptic plasticity
Although motor symptoms of PD reappear within seconds/minutes after DBS ceases 
(Temeperli et al., 2003), several pieces of evidence indicate a mechanistic role for synaptic 
plasticity in the therapeutic effects of DBS. The maximum benefits on tremor and rigidity 
are reached with a delay of minutes after the switching on of DBS, whereas the delay in 
reaching maximum benefit for akinesia may be minutes to hours (Krack et al., 2002). 
Furthermore, it is often necessary to adjust and refine stimulus parameters over the lifetime 
of DBS therapy (Krack et al., 2002), indicating some slowly evolving synaptic or other 
change associated with disease progression. Moreover, it has long been recognized that the 
stimulation frequency is the key to determining clinical efficacy in Parkinsonism. When 
DBS is directed to the STN, clinical benefits become evident at stimulation frequencies 
above 50 Hz, whereas stimulation at lower frequencies (5–20 Hz) exacerbates the symptoms 
of rigidity and bradykinesia (Moro et al., 2002; Fogelson et al., 2005; Eusebio et al., 2008).
With regard to movement disorders, plasticity in the cortico-striatal pathway has been 
studied extensively (Calabresi et al., 1992, 1997, 2000; see Kreitzer and Malenka, 2008 for 
review). In response to high-frequency stimulation (HFS—trains of pulses at 100 Hz), the 
glutamatergic cortico-striatal synapses undergo either long-term potentiation (LTP) or long-
term depression (LTD), with dopaminergic signaling necessary for the induction of such 
plasticity (Calabresi et al., 1997; Kreitzer and Malenka, 2005). However, Shen et al. (2008) 
reported that dopamine is not necessarily required for the induction of synaptic plasticity, 
but it is critical for the bidirectional, spike timing-dependent plasticity. Dopamine, acting in 
concert with other neurotransmitters and neuromodulators, such as glutamate, adenosine, 
and cannabinoids, displays concentration-dependent actions at D1 and D2 receptors that 
determine the direction of plasticity. Our data show that this is also the case with the cortico-
subthalamic pathway, where chronic depletion of dopamine does not eliminate plasticity, but 
rather, determines the plasticity profile in response to different stimulation protocols. As 
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acute administration of dopamine antagonists does not replicate the chronic changes in 
oscillatory dynamics associated with dopamine deletion, (Mallet et al., 2008b) and the 
presence (or absence) of dopamine may only play a role in the induction of plasticity, we 
have not attempted to reverse the synaptic depression associated with HFS by acute 
administration of the dopamine agonist apomorphine.
With the exception of one published report (Shen et al., 2003), stimulus-induced long-term 
adaptations in the synaptic weight of glutamatergic inputs to the STN have not been studied. 
However, Shen et al. (2003) showed that HFS (100 Hz for 1 min) of inputs to STN induces 
three forms of synaptic plasticity at glutamatergic synapses, including short-term 
potentiation (STP), LTP, and LTD. The STP and the LTD have paired-pulse characteristics 
that are consistent with changes in presynaptic action, whereas the characteristics of the LTP 
are more consistent with a postsynaptic action. Although we do not rule out a postsynaptic 
locus for some forms of synaptic plasticity in STN, the potentiation and depression of the 
cortico-subthalamic pathway induced by LFS and HFS, respectively, that we define here 
have presynaptic components that relate to changes in the probability of release or the 
number of release sites. Furthermore, synaptic depression induced by HFS only occurs in the 
dopamine-depleted state. Consistent with these findings, EPSCs in STN in dopamine-
depleted animals are amplified and followed by bursts of polysynaptic EPSCs, both of 
which are attenuated by HFS (Ammari et al., 2011).
Effect on pathological oscillations
Synchronized beta-frequency oscillations in the cortex and BG structures (including STN) 
are considered pathological because not only do they correlate with rigidity and brady-
kinesia but also because both beta activity and symptoms are simultaneously suppressed by 
dopamine replacement (Priori et al., 2004; Kühn et al., 2006, 2009) or DBS (Gaynor et al., 
2008; Eusebio et al., 2011). This excessive synchronization of activity is accompanied by 
increased coherence across cortico-basal ganglia networks and is thought to limit 
computational capacity through reduced information coding capacity (see Hammond et al., 
2007).
In this study, we show that, in dopamine-intact tissue, LFS increases the weight of 
glutamatergic synaptic inputs and that, in the dopamine-depleted state, the beneficial effects 
of HFS are consistent with synaptic depression. As HFS reduces glutamate input and DBS 
reduces beta oscillations and motor symptoms, then beta activity and other pathological 
changes might be supported by cortico-subthalamic input that is abnormally strengthened 
after dopamine loss. Further support for this idea can be found in a recent computational 
modeling study (Moran et al., 2011). The increase in the relative weight of cortico-
subthalamic synapses is therefore one way by which the STN becomes sensitized to 
oscillatory cortical inputs, resulting in increased pathological bursting activity that is 
coherent with cortical activity. As the cortex appears to play a critical role in manifestation 
of pathological oscillations, it provides an alternative, less invasive site of stimulation, 
which still requires optimum stimulation paradigms to be determined for best symptomatic 
relief.
YAMAWAKI et al. Page 10
Neuroscience. Author manuscript; available in PMC 2014 November 27.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Acknowledgments
This work is supported by Parkinson’s UK grant G-071 and The Medical Research Council, UK.
Abbreviations
BG basal ganglia
DBS deep brain stimulation
eEPSC evoked excitatory postsynaptic current
EPSC excitatory post synaptic current
GP globus pallidus
HFS high-frequency stimulation
IEI inter-event interval
LFS low-frequency stimulation
PD Parkinson’s disease
PPR paired pulse ratio
STN subthalamic nucleus
STP short-term potentiation
6-OHDA 6-hydroxydopamine
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Fig. 1. No effect of high-frequency stimulation on glutamatergic EPSCs in STN neurons in 
dopamine-intact slices.
(A) Normalized evoked EPSC amplitude (P1) 10 min before and 30 min after application of 
HFS (n=8 neurons). Each data point represents the mean (± SEM) of six evoked responses 
per neuron that were averaged across all neurons. Initiation of HFS (100 pulses at 100 Hz) is 
at time zero. (B) Paired evoked EPSCs (P1 and P2, average of 10 consecutive traces) 
separated by an interstimulus interval of 50 ms before (black) and 20 min after (red) HFS. 
(C) Paired pulse ratio (P2/P1) 10 min before and 30 min after application of HFS (n=8). (D) 
Shows the relative changes in normalized P1 EPSC amplitude plotted against the relative 
changes in CV-2 induced by HFS for each neuron recorded (white circles) and their average 
(black). (E) Raw traces showing spontaneous EPSCs before (black) and 20 min after (red) 
HFS (five consecutive sweeps). (F) Cumulative probability plots of interevent interval (IEI) 
before (black) and after (red) HFS (P>0.05).
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Fig. 2. High-frequency stimulation depresses glutamatergic EPSCs in STN neurons in dopamine-
depleted slices.
(A) Normalized eEPSC (P1) amplitude 10 min before and 30 min after application of HFS 
(n=6 neurons). (B) Paired evoked EPSCs (P1 and P2) before (black) and 20 min after (red) 
HFS. (C) Paired pulse ratio 10 min before and 30 min after application of HFS (n=6). (D) 
Shows the relative changes in normalized P1 EPSC amplitude plotted against the relative 
changes in CV−2 induced by HFS for each recording (white circles) and their average 
(black). (E) Raw traces showing sEPSCs before (black) and 20 min after (red) HFS. (F) 
Cumulative probability plots of IEIs before (black) and after (red) HFS (P<0.005).
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Fig. 3. Low-frequency stimulation potentiates glutamatergic EPSCs in STN neurons in 
dopamine-intact slices.
(A) Normalized evoked EPSC (P1) amplitude 10 min before and 30 min after application of 
LFS (n=7 neurons). Duration of LFS (10 pulses at 40 Hz delivered every second for 5 min) 
is indicated by blue bar. Each data point represents the mean (± SEM) of six evoked 
responses per neuron that were averaged across all neurons. (B) Typical paired EPSCs (P1 
and P2, average of 10 consecutive traces in one neuron) evoked before (black) and 20 min 
after (red) LFS. (C) Paired pulse ratio (P2/P1) 10 min before and 30 min after application of 
LFS (n=7). (D) Shows the relative changes in normalized P1 EPSC amplitude plotted 
against the relative changes in CV−2 induced by LFS for each neuron recorded (white) and 
their average (black). (E) Raw traces showing sEPSCs before (black) and 20 min after (red) 
LFS (five consecutive sweeps) (F) Cumulative probability plots of interevent interval (IEI) 
before (black) and after (red) LFS (P<0.001).
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Fig. 4. No effect of low-frequency stimulation on glutamatergic EPSCs in STN neurons in 
dopamine-depleted slices.
(A) Normalized eEPSC (P1) amplitude 10 min before and 30 min after application of HFS 
(n=6). (B) Paired evoked EPSCs (P1 and P2) before (black) and 30 min after (red) LFS. (C) 
Paired pulse ratio (P2/P1) 10 min before and 30 min after application of LFS (n=6). (D) 
Shows the relative changes in normalized P1 EPSC amplitude plotted against the relative 
changes in CV−2 induced by LFS. (E) Raw traces showing sEPSCs before (black) and 20 
min after (red) HFS. (F) Cumulative probability plots of interevent interval (IEI) before 
(black) and after (red) LFS (P>0.05).
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Fig. 5. Summary scheme of frequency selectivity and dopamine dependence of plasticity at 
cortico-subthalamic synapses.
This figure illustrates the potential increase in synaptic weight of cortico-subthalamic input 
promoted by the depletion of dopamine, the definitive pathology in Parkinson’s disease. 
High-frequency stimulation (HFS) of glutamatergic inputs to STN, which mimics deep brain 
stimulation (DBS), has no effect in dopamine-intact slices but elicits synaptic depression in 
dopamine-depleted slices. In contrast, low-frequency stimulation (LFS), which mimics 
pathological bursting, has no effect in dopamine-depleted but elicits synaptic potentiation in 
the dopamine-intact slices.
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